Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A7HP03

Entry ID Method Resolution Chain Position Source
AF-A7HP03-F1 Predicted AlphaFoldDB

No variants for A7HP03

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A7HP03

No associated diseases with A7HP03

5 regional properties for A7HP03

Type Name Position InterPro Accession
domain Pyruvate carboxyltransferase 31 - 309 IPR000891
conserved_site Alpha-isopropylmalate/homocitrate synthase, conserved site 38 - 54 IPR002034-1
conserved_site Alpha-isopropylmalate/homocitrate synthase, conserved site 241 - 254 IPR002034-2
domain 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain 420 - 547 IPR013709
domain LeuA, N-terminal catalytic TIM barrel domain 30 - 313 IPR039371

Functions

Description
EC Number 2.3.3.13 Acyl groups converted into alkyl groups on transfer
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
2-isopropylmalate synthase activity Catalysis of the reaction: 3-methyl-2-oxobutanoate + acetyl-CoA + H(2)O = (2S)-2-isopropylmalate + CoA + H(+).

1 GO annotations of biological process

Name Definition
leucine biosynthetic process The chemical reactions and pathways resulting in the formation of leucine, 2-amino-4-methylpentanoic acid.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MLKNPSVKYR AFAPVPLSDR QWPSKTITKP PIWMSTDLRD GNQALFEPMN AERKLRMFEM
70 80 90 100 110 120
LVKIGFKEIE AGFPSASDTD FGFIRKLVEE GRVPDDVHIE VLTQARPELI ARTMESLKGA
130 140 150 160 170 180
KNAIVHVYNA TAPNFREVVF QQGKQGVKAI ATESARQIKE IAATQPETNW TFQYSPEVFS
190 200 210 220 230 240
GTELDFAKEV VDAVTEIWEA GPERKVVINL PATVEMATPN IYADQIEWMH RNLERRDGII
250 260 270 280 290 300
LSVHPHNDRG TAVAAAELAI MAGADRVEGC LFGNGERTGN VDLVTLALNL YSQGIDPGLD
310 320 330 340 350 360
FAQINEIART AEYCTQLPIH PRHPYVGDLV FTAFSGSHQD AIKKGLAAYK AGDIWQVPYL
370 380 390 400 410 420
PLDPKDLGRT YESIIRVNSQ SGKGGVSYLL EAEYDLRLPR RLQVEFSSAV QRVTDDTGKE
430 440 450 460 470 480
VRAADIWRIF EEEYLTRAEP IEYLSHSLYD ESGKQGVKIR IRRFGKEEEL SGSGNGPIDA
490 500 510 520 530 540
AMDALKLGVE LRHYEEHSIG SGTDAKAVAF MEVADPEHPG DLFGVGIDAN IITASFKAML
550 560
SAANRAAARR PKSEWARLCG GAE